[PHARMA] QoQ Cumulative Quarter Result on 30-Jun-2012 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- 54.78%
YoY- 50.99%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 500,339 1,812,346 1,329,942 903,482 446,745 1,520,981 1,153,195 -42.65%
PBT 36,924 103,313 99,066 70,573 42,955 73,186 56,818 -24.95%
Tax -11,771 -40,108 -28,392 -25,435 -13,894 -20,401 -16,215 -19.21%
NP 25,153 63,205 70,674 45,138 29,061 52,785 40,603 -27.30%
-
NP to SH 24,771 61,710 69,645 44,398 28,685 52,157 40,215 -27.58%
-
Tax Rate 31.88% 38.82% 28.66% 36.04% 32.35% 27.88% 28.54% -
Total Cost 475,186 1,749,141 1,259,268 858,344 417,684 1,468,196 1,112,592 -43.25%
-
Net Worth 484,829 471,886 496,623 481,282 474,161 514,273 464,307 2.92%
Dividend
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Div 8,825 41,187 29,420 17,650 8,824 35,304 - -
Div Payout % 35.63% 66.74% 42.24% 39.76% 30.76% 67.69% - -
Equity
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Net Worth 484,829 471,886 496,623 481,282 474,161 514,273 464,307 2.92%
NOSH 117,676 117,677 117,683 117,672 117,657 117,682 106,983 6.55%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin 5.03% 3.49% 5.31% 5.00% 6.51% 3.47% 3.52% -
ROE 5.11% 13.08% 14.02% 9.22% 6.05% 10.14% 8.66% -
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 425.18 1,540.10 1,130.10 767.79 379.70 1,292.44 1,077.92 -46.18%
EPS 21.05 52.44 59.18 37.73 24.38 44.32 37.59 -32.03%
DPS 7.50 35.00 25.00 15.00 7.50 30.00 0.00 -
NAPS 4.12 4.01 4.22 4.09 4.03 4.37 4.34 -3.40%
Adjusted Per Share Value based on latest NOSH - 117,700
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
RPS 34.72 125.75 92.28 62.69 31.00 105.53 80.01 -42.65%
EPS 1.72 4.28 4.83 3.08 1.99 3.62 2.79 -27.54%
DPS 0.61 2.86 2.04 1.22 0.61 2.45 0.00 -
NAPS 0.3364 0.3274 0.3446 0.3339 0.329 0.3568 0.3222 2.91%
Price Multiplier on Financial Quarter End Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 -
Price 8.26 8.10 7.55 10.18 5.90 5.36 5.90 -
P/RPS 1.94 0.53 0.67 1.33 1.55 0.41 0.55 131.54%
P/EPS 39.24 15.45 12.76 26.98 24.20 12.09 15.70 84.06%
EY 2.55 6.47 7.84 3.71 4.13 8.27 6.37 -45.65%
DY 0.91 4.32 3.31 1.47 1.27 5.60 0.00 -
P/NAPS 2.00 2.02 1.79 2.49 1.46 1.23 1.36 29.28%
Price Multiplier on Announcement Date
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Date 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 -
Price 9.26 7.80 8.25 8.83 5.90 5.90 5.90 -
P/RPS 2.18 0.51 0.73 1.15 1.55 0.46 0.55 150.24%
P/EPS 43.99 14.87 13.94 23.40 24.20 13.31 15.70 98.62%
EY 2.27 6.72 7.17 4.27 4.13 7.51 6.37 -49.70%
DY 0.81 4.49 3.03 1.70 1.27 5.08 0.00 -
P/NAPS 2.25 1.95 1.95 2.16 1.46 1.35 1.36 39.83%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment